​

ResMed (RMD) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

ResMed Revenue Highlights


Latest Revenue (Y)

$5.65B

Latest Revenue (Q)

$1.41B

Main Segment (Y)

Sleep And Respiratory

Main Geography (Y)

U [S]

ResMed Revenue by Period


ResMed Revenue by Year

DateRevenueChange
2026-06-30$5.65B9.85%
2025-06-30$5.15B9.84%
2024-06-30$4.69B10.95%
2023-06-30$4.22B18.02%
2022-06-30$3.58B11.93%
2021-06-30$3.20B8.11%
2020-06-30$2.96B13.44%
2019-06-30$2.61B11.38%
2018-06-30$2.34B13.23%
2017-06-30$2.07B12.40%
2016-06-30$1.84B9.52%
2015-06-30$1.68B7.97%
2014-06-30$1.55B2.68%
2013-06-30$1.51B10.66%
2012-06-30$1.37B10.08%
2011-06-30$1.24B13.80%
2010-06-30$1.09B18.64%
2009-06-30$920.74M10.22%
2008-06-30$835.40M16.62%
2007-06-30$716.33M18.01%
2006-06-30$607.00M42.65%
2005-06-30$425.50M25.39%
2004-06-30$339.34M24.04%
2003-06-30$273.57M34.05%
2002-06-30$204.08M31.53%
2001-06-30$155.16M34.20%
2000-06-30$115.61M30.49%
1999-06-30$88.60M33.23%
1998-06-30$66.50M35.16%
1997-06-30$49.20M42.20%
1996-06-30$34.60M47.23%
1995-06-30$23.50M69.06%
1994-06-30$13.90M80.52%
1993-06-30$7.70M-

ResMed generated $5.65B in revenue during NA 2026, up 9.85% compared to the previous quarter, and up 176.85% compared to the same period a year ago.

ResMed Revenue by Quarter

DateRevenueChange
2026-09-30$1.41B-3.34%
2026-06-30$1.46B2.25%
2026-03-31$1.43B0.60%
2025-12-31$1.42B6.53%
2025-09-30$1.34B-0.92%
2025-06-30$1.35B4.36%
2025-03-31$1.29B0.75%
2024-12-31$1.28B4.70%
2024-09-30$1.22B0.11%
2024-06-30$1.22B2.19%
2024-03-31$1.20B2.94%
2023-12-31$1.16B5.49%
2023-09-30$1.10B-1.76%
2023-06-30$1.12B0.46%
2023-03-31$1.12B8.04%
2022-12-31$1.03B8.78%
2022-09-30$950.29M3.89%
2022-06-30$914.74M5.81%
2022-03-31$864.50M-3.39%
2021-12-31$894.87M-1.01%
2021-09-30$904.01M3.19%
2021-06-30$876.10M13.96%
2021-03-31$768.77M-3.91%
2020-12-31$800.01M6.39%
2020-09-30$751.94M-2.39%
2020-06-30$770.34M0.12%
2020-03-31$769.46M4.52%
2019-12-31$736.16M8.09%
2019-09-30$681.06M-3.39%
2019-06-30$704.96M6.45%
2019-03-31$662.23M1.71%
2018-12-31$651.10M10.68%
2018-09-30$588.28M-5.67%
2018-06-30$623.63M5.41%
2018-03-31$591.63M-1.60%
2017-12-31$601.27M14.82%
2017-09-30$523.66M-5.93%
2017-06-30$556.69M8.26%
2017-03-31$514.20M-3.05%
2016-12-31$530.40M13.95%
2016-09-30$465.45M-10.26%
2016-06-30$518.65M14.27%
2016-03-31$453.88M-0.15%
2015-12-31$454.54M10.42%
2015-09-30$411.65M-9.14%
2015-06-30$453.06M7.23%
2015-03-31$422.50M-0.11%
2014-12-31$422.95M11.19%
2014-09-30$380.40M-8.38%
2014-06-30$415.21M4.39%
2014-03-31$397.76M3.49%
2013-12-31$384.34M7.46%
2013-09-30$357.66M-13.73%
2013-06-30$414.61M8.09%
2013-03-31$383.58M1.87%
2012-12-31$376.54M10.83%
2012-09-30$339.73M-8.66%
2012-06-30$371.93M6.55%
2012-03-31$349.07M4.91%
2011-12-31$332.74M5.71%
2011-09-30$314.77M-7.93%
2011-06-30$341.89M9.14%
2011-03-31$313.26M2.38%
2010-12-31$305.99M8.50%
2010-09-30$282.01M-3.28%
2010-06-30$291.57M4.63%
2010-03-31$278.66M1.28%
2009-12-31$275.13M11.39%
2009-09-30$246.99M-1.97%
2009-06-30$251.96M10.57%
2009-03-31$227.87M2.19%
2008-12-31$222.98M2.32%
2008-09-30$217.93M-7.32%
2008-06-30$235.15M11.01%
2008-03-31$211.83M-

ResMed generated $1.41B in revenue during Q1 2027, up -3.34% compared to the previous quarter, and up 104.96% compared to the same period a year ago.

ResMed Revenue Breakdown


ResMed Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceJun 24Jun 23Jun 22Jun 21Jun 20
Software As Service$584.13M$497.98M$400.83M$373.59M$354.63M
Sleep And Respiratory$4.10B$3.73B$3.18B$2.82B$2.60B
Software As A Service-$497.98M---

ResMed's latest annual revenue breakdown by segment (product or service), as of Jun 24: Sleep And Respiratory (87.53%), and Software As Service (12.47%).

Quarterly Revenue by Product

Product/ServiceSep 26Dec 25Sep 25Dec 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20
Sleep And Respiratory$1.26B$1.26B$1.17B$1.13B$1.07B$1.05B$1.02B$963.04M$983.48M$980.12M$916.98M$844.44M$763.36M$795.84M$806.50M$780.33M$674.93M$708.18M$659.80M-
Residential Care Software$155.01M$166.87M$166.14M$156.50M----------------
Software As Service----$151.94M$147.96M$144.95M$139.28M$136.78M$116.76M$105.85M$101.14M$99.03M$97.52M$95.78M$91.48M----
Software As Service Before Deferred Revenue Adjustment-------------------$91.48M
Devices And Masks-------------------$678.87M

ResMed's latest quarterly revenue breakdown by segment (product or service), as of Sep 26: Sleep And Respiratory (89.04%), and Residential Care Software (10.96%).

ResMed Revenue Breakdown by Country

Annual Revenue by Country

CountryJun 24Jun 23Jun 22Jun 21Jun 20
Global$1.71B$1.50B$3.58B$3.20B$2.96B
U [S]$2.98B$2.72B---
Rest Of World-$1.50B---
UNITED STATES-$2.72B---
U.s. Canada And Latin America--$2.38B$2.08B$1.93B

ResMed's latest annual revenue breakdown by geography, as of Jun 24: U [S] (63.60%), and Global (36.40%).

Quarterly Revenue by Country

CountrySep 26Dec 25Sep 25Dec 24Sep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Sleep And Breathing Health$833.42M-------------------
Software As Service$155.01M-------------------
Combined Europe Asia And Other Markets-$420.91M$394.69M$376.64M$360.43M$361.55M$348.52M$324.68M$115.16M$104.45M$266.34M$287.93M$309.03M$315.46M$99.21M$93.42M$80.62M---
Global-$166.87M$166.14M$156.50M$1.22B$1.20B$1.16B$1.10B$1.12B$136.78M$116.76M$105.85M$914.74M$101.14M$99.03M$97.52M$876.10M$93.84M$91.83M$92.14M
Us Canada And Latin America-$835.03M$774.75M$748.95M$707.31M$687.47M$669.33M$638.36M$257.07M$269.73M$105.85M$101.14M$99.03M$97.52M$93.84M$91.83M$92.14M---

ResMed's latest quarterly revenue breakdown by geography, as of Sep 26: Sleep And Breathing Health (84.32%), and Software As Service (15.68%).

ResMed Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
MDTMedtronic$36.36B$9.76B
BSXBoston Scientific$20.07B$5.14B
GEHCGE HealthCare$19.60B$5.51B
PHGKoninklijke Philips$18.17B$4.14B
ISRGIntuitive Surgical$10.06B$3.05B
RMDResMed$5.65B$1.41B
TFXTeleflex$1.99B$567.78M
INSPInspire Medical Systems$911.98M$206.69M

RMD Revenue FAQ


What is ResMed’s yearly revenue?

ResMed's yearly revenue for 2026 was $5.65B, representing an increase of 9.85% compared to 2025. The company's yearly revenue for 2025 was $5.15B, representing an increase of 9.84% compared to 2024. RMD's yearly revenue for 2024 was $4.69B, representing an increase of 10.95% compared to 2023.

What is ResMed’s quarterly revenue?

ResMed's quarterly revenue for Q1 2027 was $1.41B, a -3.34% decrease from the previous quarter (Q4 2026), and a 5.93% increase year-over-year (Q1 2026). The company's quarterly revenue for Q4 2026 was $1.46B, a 2.25% increase from the previous quarter (Q3 2026), and a 8.58% increase year-over-year (Q4 2025). RMD's quarterly revenue for Q3 2026 was $1.43B, a 0.60% increase from the previous quarter (Q2 2026), and a 10.81% increase year-over-year (Q3 2025).

What is ResMed’s revenue growth rate?

ResMed's revenue growth rate for the last 3 years (2024-2026) was 20.66%, and for the last 5 years (2022-2026) was 58.00%.

What are ResMed’s revenue streams?

ResMed's revenue streams in n 24 are Software As Service, and Sleep And Respiratory. Software As Service generated $584.12M in revenue, accounting 12.47% of the company's total revenue, up 17.30% year-over-year. Sleep And Respiratory generated $4.1B in revenue, accounting 87.53% of the company's total revenue, up 10.10% year-over-year.

What is ResMed’s main source of revenue?

For the fiscal year ending Jun 24, the largest source of revenue of ResMed was Sleep And Respiratory. This segment made a revenue of $4.1B, representing 87.53% of the company's total revenue.